Summary of Classification and Labelling
Notified classification and labelling
General Information
829-217-6 |
lithium 3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-ide |
1449413-05-1 |
Notified classification and labelling according to CLP criteria
Eye Dam. 1 |
H318
|
H318
|
|
GHS08 GHS05 Dgr
|
|
|
|
|
1 |
|
View details
|
Repr. 2 |
H361
|
H361
|
STOT RE 2 |
H373
(adrenal glands,...)
(oral)
|
H373
|
Number of Aggregated Notifications: 1